Frank Lichtenberg : Citation Profile

Are you Frank Lichtenberg?

National Bureau of Economic Research (NBER) (30% share)
CESifo (10% share)
Columbia University (60% share)

27

H index

47

i10 index

3405

Citations

RESEARCH PRODUCTION:

86

Articles

89

Papers

13

Chapters

RESEARCH ACTIVITY:

   43 years (1981 - 2024). See details.
   Cites by year: 79
   Journals where Frank Lichtenberg has often published
   Relations with other researchers
   Recent citing documents: 92.    Total self citations: 82 (2.35 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pli76
   Updated: 2024-12-03    RAS profile: 2024-09-28    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Blankart, Katharina (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Frank Lichtenberg.

Is cited by:

Hall, Bronwyn (30)

van Reenen, John (29)

Madsen, Jakob (21)

Quatraro, Francesco (19)

Siegel, Donald (19)

Wiederhold, Simon (18)

Keller, Wolfgang (18)

MAIRESSE, Jacques (17)

van Pottelsberghe de la Potter, Bruno (16)

Vivarelli, Marco (16)

Ang, James (16)

Cites to:

Lleras-Muney, Adriana (18)

Sakellaris, Plutarchos (13)

Wilson, Daniel (13)

Siegel, Donald (12)

Nordhaus, William (12)

Helpman, Elhanan (12)

Romer, Paul (12)

topel, robert (9)

Acemoglu, Daron (9)

Linn, Joshua (9)

Murphy, Kevin (9)

Main data

Where Frank Lichtenberg has published?

Journals with more than one article published# docs
Forum for Health Economics & Policy7
Economics of Innovation and New Technology5
The Review of Economics and Statistics5
American Economic Review4
International Journal of Health Economics and Management4
Social Science & Medicine3
Economics & Human Biology3
Journal of Economic Behavior & Organization3
Journal of Industrial Economics3
International Journal of the Economics of Business2
Journal of Law and Economics2
Research Policy2
Annals of Economics and Statistics2
PharmacoEconomics2
Managerial and Decision Economics2

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc57
CESifo Working Paper Series / CESifo9
Working Papers / Center for Economic Studies, U.S. Census Bureau3
ULB Institutional Repository / ULB -- Universite Libre de Bruxelles2
SOI - Working Papers / Socioeconomic Institute - University of Zurich2

Recent works citing Frank Lichtenberg (2024 and 2023)

YearTitle of citing document
2024.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023The effect of capital and labour distortion on innovation. (2023). Liang, Yidan. In: Accounting and Finance. RePEc:bla:acctfi:v:63:y:2023:i:2:p:1709-1737.

Full description at Econpapers || Download paper

2023Does outward foreign direct investment improve the performance of domestic firms? Case of Korea. (2023). Kim, Sung Hyun ; Han, Soomin. In: Asian Economic Journal. RePEc:bla:asiaec:v:37:y:2023:i:4:p:519-549.

Full description at Econpapers || Download paper

2023Quantifying the economy?wide returns to innovation for Australia. (2022). Cohen, Jasmine ; Liu, Mingji ; Wynn, Katherine. In: Australian Economic Papers. RePEc:bla:ausecp:v:61:y:2022:i:3:p:591-614.

Full description at Econpapers || Download paper

2023Earnings Management of Chinese Listed Multinational Corporations. (2023). Xie, Wenjing ; Qi, Tong ; Lu, Xingyu. In: China & World Economy. RePEc:bla:chinae:v:31:y:2023:i:6:p:179-206.

Full description at Econpapers || Download paper

2023Biased Beliefs and Stigma as Barriers to Treatment and Innovation Adoption. (2023). Lasio, Laura ; Grigolon, Laura. In: CRC TR 224 Discussion Paper Series. RePEc:bon:boncrc:crctr224_2023_277v2.

Full description at Econpapers || Download paper

2023Moderating Role of Board Size between the Board Characteristics and the Bank’s Performance: Application of GMM. (2023). Twumwaah, Deborah Adu ; Gyamera, Emmanuel ; Mohammed, Ibrahim ; Eklemet, Ivy. In: International Journal of Economics and Financial Issues. RePEc:eco:journ1:2023-03-15.

Full description at Econpapers || Download paper

2024Foreign investors, firm level productivity, and European economic integration. (2024). Phylaktis, Kate ; Onay, Ceylan ; Muradoglu, Gulnur ; Bailey, Warren. In: Journal of Corporate Finance. RePEc:eee:corfin:v:85:y:2024:i:c:s0929119924000269.

Full description at Econpapers || Download paper

2023Does it hurt or help? Revisiting the effects of ICT on economic growth and energy consumption: A nonlinear panel ARDL approach. (2023). Vo, Xuan Vinh ; Farouk, Sherine ; Nghiem, Xuan-Hoa ; Bakry, Walid. In: Economic Analysis and Policy. RePEc:eee:ecanpo:v:78:y:2023:i:c:p:597-617.

Full description at Econpapers || Download paper

2023Ownership, volatility, and equity incentives: Theory and evidence from listed companies in China. (2023). Zhou, Min ; Wu, Hong ; Tang, Yue ; Kou, Zonglai. In: Economic Modelling. RePEc:eee:ecmode:v:128:y:2023:i:c:s0264999323002821.

Full description at Econpapers || Download paper

2023Understanding R&D transitions: From bottom to top?. (2023). Bravo-Ortega, Claudio ; Alvarez, Roberto ; Poniachik, Dan. In: Economic Systems. RePEc:eee:ecosys:v:47:y:2023:i:4:s0939362523000821.

Full description at Econpapers || Download paper

2023Capacity utilization shifting or resource-seeking? Benefits for Chinese enterprises participating in the belt and road initiative. (2023). Yang, Hao ; Zhang, Xuejiao ; Cai, Guowei. In: Emerging Markets Review. RePEc:eee:ememar:v:54:y:2023:i:c:s156601412300002x.

Full description at Econpapers || Download paper

2023Regulation-induced financial constraints, carbon emission and corporate innovation: Evidence from China. (2023). Ding, Mingfa ; Cui, DI ; Suardi, Sandy ; Han, Yikai. In: Energy Economics. RePEc:eee:eneeco:v:127:y:2023:i:pb:s0140988323005790.

Full description at Econpapers || Download paper

2023Corporate digital transformation and labor structure upgrading. (2023). Chang, Xiaochen ; Guo, Songlin ; Dou, Bin ; Wang, Yong. In: International Review of Financial Analysis. RePEc:eee:finana:v:90:y:2023:i:c:s1057521923004209.

Full description at Econpapers || Download paper

2024Reasons for M&A: A perspective from senior executives rural experiences- Evidence from Chinese private listed companies. (2024). He, Xiaogang ; Peng, Jinxia ; Xiao, Xiaohong. In: International Review of Financial Analysis. RePEc:eee:finana:v:93:y:2024:i:c:s1057521924001418.

Full description at Econpapers || Download paper

2024Political risk of green public procurement and firms green innovation. (2024). Liu, Chengxin ; Huang, Xiang ; Wang, Jiaxin ; Song, Zilong ; Sun, DI. In: Finance Research Letters. RePEc:eee:finlet:v:62:y:2024:i:pb:s1544612324002654.

Full description at Econpapers || Download paper

2023Subsidy and taxation in all-pay auctions under incomplete information. (2023). Sela, Aner ; Minchuk, Yizhaq. In: Games and Economic Behavior. RePEc:eee:gamebe:v:140:y:2023:i:c:p:99-114.

Full description at Econpapers || Download paper

2024The behavioral additionality of government research grants. (2024). Widmann, Rainer. In: International Journal of Industrial Organization. RePEc:eee:indorg:v:93:y:2024:i:c:s0167718723001145.

Full description at Econpapers || Download paper

2023Technology adoption and specialized labor. (2023). Pulina, Giuseppe ; Carroni, Elias ; Delogu, Marco. In: International Economics. RePEc:eee:inteco:v:173:y:2023:i:c:p:249-259.

Full description at Econpapers || Download paper

2023Interactive R&D spillovers: An estimation strategy based on forecasting-driven model selection. (2023). Simioni, Michel ; Musolesi, Antonio ; Gioldasis, Georgios. In: International Journal of Forecasting. RePEc:eee:intfor:v:39:y:2023:i:1:p:144-169.

Full description at Econpapers || Download paper

2023Is downsizing a good strategy during the downturn? Evidence from Taiwanese manufacturing firms. (2023). Hsiao, Yi-Chi ; Lin, Hui-Lin. In: Japan and the World Economy. RePEc:eee:japwor:v:65:y:2023:i:c:s0922142522000561.

Full description at Econpapers || Download paper

2024The nonlinear relationship between employee stock ownership plans and firm performance: Evidence from China. (2024). Dasilas, Apostolos. In: Journal of Business Research. RePEc:eee:jbrese:v:173:y:2024:i:c:s0148296323008299.

Full description at Econpapers || Download paper

2023What do outside CEOs really do? Evidence from plant-level data. (2023). Mkrtchyan, Anahit ; Bai, John. In: Journal of Financial Economics. RePEc:eee:jfinec:v:147:y:2023:i:1:p:27-48.

Full description at Econpapers || Download paper

2024Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D. (2024). Hermosilla, Manuel. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629623001327.

Full description at Econpapers || Download paper

2024Growth gains from offshore outsourcing. (2024). Veeramani, C ; Marjit, Sugata ; Basu, Anwesha. In: Journal of Policy Modeling. RePEc:eee:jpolmo:v:46:y:2024:i:1:p:90-112.

Full description at Econpapers || Download paper

2023A novel measure of firm-level production outsourcing. (2023). Rodriguez, Mauricio ; Swink, Morgan ; Kovach, Jeremy J. In: International Journal of Production Economics. RePEc:eee:proeco:v:263:y:2023:i:c:s092552732300172x.

Full description at Econpapers || Download paper

2023US foreign investments: Technology transfer, relative backwardness, and the productivity growth of host countries. (2023). Djermane, Rebai ; Khedhaouria, Anis ; Ftiti, Zied ; Benzaim, Samia. In: The Quarterly Review of Economics and Finance. RePEc:eee:quaeco:v:87:y:2023:i:c:p:275-295.

Full description at Econpapers || Download paper

2023Pathways to self-sufficiency in the microfinance ecosystem. (2023). Fuertes-Callen, Yolanda ; Cuellar-Fernandez, Beatriz ; Serrano-Cinca, Carlos. In: The Quarterly Review of Economics and Finance. RePEc:eee:quaeco:v:92:y:2023:i:c:p:262-273.

Full description at Econpapers || Download paper

2023Money matters: The role of money as a regional and corporate financial resource for circular economy transition at firm-level. (2023). Stucki, Tobias ; Meili, Rahel. In: Research Policy. RePEc:eee:respol:v:52:y:2023:i:10:s0048733323001683.

Full description at Econpapers || Download paper

2023Does public R&D funding crowd-in private R&D investment? Evidence from military R&D expenditures for US states. (2023). Pallante, Gianluca ; Roventini, Andrea ; Russo, Emanuele. In: Research Policy. RePEc:eee:respol:v:52:y:2023:i:8:s0048733323000914.

Full description at Econpapers || Download paper

2023OFDI and firms sustainable productive capacity: Evidence from Chinese industrial firms. (2023). Kong, Qunxi ; Ji, Y ; Peng, Dan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:83:y:2023:i:c:p:641-652.

Full description at Econpapers || Download paper

2023The impact of quality of institutions on firm performance: A global analysis. (2023). Chang, Chong-Chuo. In: International Review of Economics & Finance. RePEc:eee:reveco:v:83:y:2023:i:c:p:694-716.

Full description at Econpapers || Download paper

2024Stock return volatility and financial distress: Moderating roles of ownership structure, managerial ability, and financial constraints. (2024). Nguyen, Manh Huu ; Barky, Walid ; van Nguyen, Phuc ; Huong, Giang Thi. In: International Review of Economics & Finance. RePEc:eee:reveco:v:91:y:2024:i:c:p:634-652.

Full description at Econpapers || Download paper

2024Evaluating the impact of OFDI on the growth quality of industrial firms: A dual-perspective analysis from China. (2024). Cai, Molly ; Kong, Qunxi ; Wang, Ziqi ; Peng, Dan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:1616-1627.

Full description at Econpapers || Download paper

2023Rising to the challenge or perish? Chinese import penetration and its impact on growth dynamics of manufacturing firms in South Africa. (2023). Andreoni, Antonio ; Torreggiani, Sofia. In: Structural Change and Economic Dynamics. RePEc:eee:streco:v:64:y:2023:i:c:p:199-212.

Full description at Econpapers || Download paper

2024University procurement-led innovation: Sources, procedures, and effects. Some field-study evidence. (2024). Patsali, Sofia. In: Technovation. RePEc:eee:techno:v:130:y:2024:i:c:s0166497223002122.

Full description at Econpapers || Download paper

2024Beyond funding: The moderating role of firms R&D human capital on government support and venture capital for regional innovation in China. (2024). Prevot, Frederic ; Edeh, Jude. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:203:y:2024:i:c:s0040162524001471.

Full description at Econpapers || Download paper

2023The gender labor productivity gap across informal firms. (2023). Islam, Asif ; Amin, Mohammad. In: World Development. RePEc:eee:wdevel:v:167:y:2023:i:c:s0305750x23000475.

Full description at Econpapers || Download paper

2024Do trade agreements contribute to the decline in labor share? Evidence from Latin American countries. (2024). Ruffo, Hernán ; Gonzalez-Rozada, Martin. In: World Development. RePEc:eee:wdevel:v:177:y:2024:i:c:s0305750x24000317.

Full description at Econpapers || Download paper

2023Absorptive capacity, learning and profiting from outward FDI: Evidence from Canadian firms. (2023). Wang, Weimin ; Tang, Jianmin ; Hejazi, Walid. In: Journal of World Business. RePEc:eee:worbus:v:58:y:2023:i:3:s1090951623000020.

Full description at Econpapers || Download paper

2023Managerial ownership and financial distress: evidence from the Chinese stock market. (2023). Troshani, Indrit ; Zhang, LU ; Wang, Jimin. In: International Journal of Managerial Finance. RePEc:eme:ijmfpp:ijmf-06-2022-0270.

Full description at Econpapers || Download paper

2023University as a Knowledge Source of Innovation: A spatial analysis of the impact on local high-tech startup creation. (2023). Qiuhan, Zhao ; Kazuyuki, Motohashi. In: Discussion papers. RePEc:eti:dpaper:23027.

Full description at Econpapers || Download paper

2023Pre-LBO Credit Market Conditions and Post-LBO Target Behavior. (2023). Press, Charles ; Kwak, Seung. In: Finance and Economics Discussion Series. RePEc:fip:fedgfe:2023-77.

Full description at Econpapers || Download paper

2023A Perspective on Management Myopia: The Impact of Digital Transformation on Carbon Emission Intensity. (2023). Tao, Pan ; Ma, YU. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:12:p:9417-:d:1169095.

Full description at Econpapers || Download paper

2023A Multi-Regional Input–Output Model to Measure the Spatial Spillover of R&D Capital. (2023). Xu, Lixiao ; Xing, Senyu ; Wang, Chunyun. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:14:p:11208-:d:1196921.

Full description at Econpapers || Download paper

2023Heterogeneous Effects of Public Procurement on Environmental Innovation, Evidence from European Companies. (2023). Wang, Qunwei ; Morotomi, Toru ; Yu, Chunling. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:19:p:14354-:d:1250303.

Full description at Econpapers || Download paper

2023OFDI, Industrial Structure Upgrading and Green Development—Spatial Effect Based on China’s Evidence. (2023). Zhou, Yuan ; Xu, Shan. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:3:p:2810-:d:1057159.

Full description at Econpapers || Download paper

2023Effects of Science, Technology, and Innovation Official Development Assistance on Innovative Capacity in Developing Countries. (2023). Cho, Keuntae ; Choi, Hyunyi. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:4:p:2906-:d:1059158.

Full description at Econpapers || Download paper

2023The Effect of Outward FDI on Capabilities of Sustained Innovation: Evidence from China. (2023). Zhao, Shiyong ; Ye, Yunxin. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:5:p:4196-:d:1080682.

Full description at Econpapers || Download paper

2023Empirical Research on the Impact of China’s Overseas Economic and Trade Cooperation Zones on the Development of Host Countries in the Global Value Chain. (2023). Sun, Churen ; Qin, Qing. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:6:p:4853-:d:1092077.

Full description at Econpapers || Download paper

2023What Drives Industry 4.0 Technologies Adoption? Evidence from a SEM-Neural Network Approach in the Context of Vietnamese Firms. (2023). Pham, Khanh Duy ; Nguyen, Tien Hoang ; Toan, Vu Linh. In: Sustainability. RePEc:gam:jsusta:v:15:y:2023:i:7:p:5969-:d:1111273.

Full description at Econpapers || Download paper

2024Does Quality Certification or Product Diversification Improve the Performance of Small and Medium Enterprises?. (2024). Nguyen, Van-Hoa ; Le, Duc-Niem. In: Sustainability. RePEc:gam:jsusta:v:16:y:2024:i:5:p:2023-:d:1348778.

Full description at Econpapers || Download paper

2023Healthcare Procurement and Firm Innovation: Evidence from AI-powered Equipment. (2023). Pezzoni, Michele ; Krafft, Jackie ; Patsali, Sofia. In: GREDEG Working Papers. RePEc:gre:wpaper:2023-05.

Full description at Econpapers || Download paper

2023Market concentration, agency cost and firm performance: a case study on Indian corporate firms. (2023). Chakraborty, Indrani ; Roy, Ujjayini. In: Economic Change and Restructuring. RePEc:kap:ecopln:v:56:y:2023:i:4:d:10.1007_s10644-023-09529-1.

Full description at Econpapers || Download paper

2023The struggle of small firms to retain high-skill workers: job duration and the importance of knowledge intensity. (2023). Lima, Francisco ; Castro-Silva, Hugo. In: Small Business Economics. RePEc:kap:sbusec:v:60:y:2023:i:2:d:10.1007_s11187-022-00602-z.

Full description at Econpapers || Download paper

2023Mapping the venture capital and private equity research: a bibliometric review and future research agenda. (2023). Pandey, Nitesh ; Lim, Weng Marc ; Kumar, Satish ; Cumming, Douglas. In: Small Business Economics. RePEc:kap:sbusec:v:61:y:2023:i:1:d:10.1007_s11187-022-00684-9.

Full description at Econpapers || Download paper

2023What drives the valuation of entrepreneurial ventures? A map to navigate the literature and research directions. (2023). Vismara, Silvio ; Montanaro, Benedetta ; Colombo, Massimo G. In: Small Business Economics. RePEc:kap:sbusec:v:61:y:2023:i:1:d:10.1007_s11187-022-00688-5.

Full description at Econpapers || Download paper

2023Exploring the double-edged sword effect of outward FDI spillovers on domestic firms’ productivity in an emerging market. (2023). Han, Sanghyun ; Xiao, Shufeng Simon ; Wang, Mengmeng. In: Asian Business & Management. RePEc:pal:abaman:v:22:y:2023:i:1:d:10.1057_s41291-021-00166-y.

Full description at Econpapers || Download paper

2023The impact of tax-subsidized health insurance on health and out-of-pocket burden in China. (2023). Wei, LI ; Yang, Feiyan. In: The Geneva Papers on Risk and Insurance - Issues and Practice. RePEc:pal:gpprii:v:48:y:2023:i:1:d:10.1057_s41288-022-00276-4.

Full description at Econpapers || Download paper

2023Does club convergence matter? Empirical evidence on inequality in the human development index among Indian states. (2023). Pradhan, Jalandhar ; Nag, Ajit. In: Palgrave Communications. RePEc:pal:palcom:v:10:y:2023:i:1:d:10.1057_s41599-023-01518-z.

Full description at Econpapers || Download paper

2024Multifactor productivity growth enhancers across industries and countries: Firm-level evidence. (2024). Nakatani, Ryota. In: MPRA Paper. RePEc:pra:mprapa:120503.

Full description at Econpapers || Download paper

2023The Behavioral Additionality of Government Research Grants. (2023). Widmann, Rainer. In: Rationality and Competition Discussion Paper Series. RePEc:rco:dpaper:417.

Full description at Econpapers || Download paper

2023Optimizing good Corporate Governance Mechanism to Improve Performance: Case in Indonesia’s Manufacturing Companies. (2023). Nugroho, Widyo ; Basuki, Ferry Hendro ; Situngkir, Anggiat ; Napitupulu, Ilham Hidayah. In: Global Business Review. RePEc:sae:globus:v:24:y:2023:i:6:p:1205-1226.

Full description at Econpapers || Download paper

2023Financial Development and International R&D Spillovers Through Trade: Evidence From Developing Countries. (2023). Le, Thanh ; Bui, Hung ; Nguyen, HA ; Mai, Sau ; Vu, Ngoc. In: SAGE Open. RePEc:sae:sagope:v:13:y:2023:i:1:p:21582440231163842.

Full description at Econpapers || Download paper

2023Public subsidies and innovation: a doubly robust machine learning approach leveraging deep neural networks. (2023). Sickles, Robin ; Varaku, Kerda. In: Empirical Economics. RePEc:spr:empeco:v:64:y:2023:i:6:d:10.1007_s00181-023-02398-7.

Full description at Econpapers || Download paper

2023Assessing the impact of reverse technology spillover of outward foreign direct investment on energy efficiency. (2023). Liao, Nuo ; Zuo, Hongyan ; He, Yong. In: Environment, Development and Sustainability: A Multidisciplinary Approach to the Theory and Practice of Sustainable Development. RePEc:spr:endesu:v:25:y:2023:i:5:d:10.1007_s10668-022-02204-x.

Full description at Econpapers || Download paper

2023Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4.

Full description at Econpapers || Download paper

2023Cross‐border mergers and acquisitions: does the exchange rate matter? Some evidence for Canada. (2008). Georgopoulos, George J. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:41:y:2008:i:2:p:450-474.

Full description at Econpapers || Download paper

2023Skill?replacing process innovation and the labour market: Theory and evidence. (2023). Zhu, Wenbo. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:56:y:2023:i:4:p:1583-1614.

Full description at Econpapers || Download paper

2023Public governance and firm total factor productivity: Evidence from a quasi?natural event in China. (2023). Li, Zhenjun ; Cheng, Maoyong. In: Economics of Transition and Institutional Change. RePEc:wly:ectrin:v:31:y:2023:i:3:p:683-719.

Full description at Econpapers || Download paper

2023‘Going global’ and pollution in home country: Evidence from Chinese industrial firms. (2023). He, Lingyun ; Lin, XI. In: Economics of Transition and Institutional Change. RePEc:wly:ectrin:v:31:y:2023:i:4:p:1135-1174.

Full description at Econpapers || Download paper

2024Financial incentives and prescribing behavior in primary care. (2024). Herr, Annika ; Gravelle, Hugh ; Bodnar, Olivia ; Gutacker, Nils. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:696-713.

Full description at Econpapers || Download paper

2023Public procurement as an innovation policy: Where do we stand?. (2023). Spagnolo, Giancarlo ; Giuffrida, Leonardo M ; Chiappinelli, Olga. In: ZEW Discussion Papers. RePEc:zbw:zewdip:23002.

Full description at Econpapers || Download paper

2024Public procurement can hinder innovation. (2024). Strecke, Linus ; Pruefer, Malte ; Krieger, Bastian. In: ZEW Discussion Papers. RePEc:zbw:zewdip:287768.

Full description at Econpapers || Download paper

Works by Frank Lichtenberg:

YearTitleTypeCited
1998The Impact and Organization of Publicly-Funded Research and development in the European Community In: Annals of Economics and Statistics.
[Full Text][Citation analysis]		article27
1997The Impact and Organization of Publicly-Funded Research and Development in the European Community.(1997) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 27		paper
2005Are the More Educated More Likely to Use New Drugs? In: Annals of Economics and Statistics.
[Full Text][Citation analysis]		article39
2010Are the More Educated More Likely to Use New Drugs?.(2010) In: NBER Chapters.
[Citation analysis]
This paper has nother version. Agregated cites: 39		chapter
1984The Relationship between Federal Contract R&D and Company R&D. In: American Economic Review.
[Citation analysis]		article83
1988The Private R&D Investment Response to Federal Design and Technical Competitions. In: American Economic Review.
[Full Text][Citation analysis]		article110
1996Do (More and Better) Drugs Keep People Out of Hospitals? In: American Economic Review.
[Full Text][Citation analysis]		article31
2007The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data In: American Economic Review.
[Full Text][Citation analysis]		article16
1989Errors of Measurement in Output Deflators. In: Journal of Business & Economic Statistics.
[Citation analysis]		article25
1986Errors of Measurement in Output Deflators.(1986) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 25		paper
1987Productivity and Changes in Ownership of Manufactoring Plants In: Brookings Papers on Economic Activity.
[Full Text][Citation analysis]		article92
2017The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia In: The Economic Record.
[Full Text][Citation analysis]		article1
1989THE EFFECT OF CONTROL CHANGES ON THE PRODUCTIVITY OF U.S. MANUFACTURING PLANTS In: Journal of Applied Corporate Finance.
[Full Text][Citation analysis]		article5
1987The Effect of Government Funding on Private Industrial Research and Development: A Re-assessment. In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article68
1989Contributions to Federal Election Campaigns by Government Contractors. In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article2
1988CONTRIBUTIONS TO FEDERAL ELECTION CAMPAIGNS BY GOVERNMENT CONTRACTORS.(1988) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 2		paper
1998Computer Use and Productivity Growth in US Federal Government Agencies, 1987–92 In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article15
2010Pharmaceutical Price Discrimination and Social Welfare In: Capitalism and Society.
[Full Text][Citation analysis]		article3
2008Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article1
2007Pharmaceutical Innovation and US Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data.(2007) In: NBER Chapters.
[Citation analysis]
This paper has nother version. Agregated cites: 1		chapter
2010Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article3
2010Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia.(2010) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 3		paper
2013The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article13
2012The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files.(2012) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 13		paper
2017The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004–2012 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2018The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries: A Two-Way Fixed-Effects Analysis In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2019The impact of new drug launches on hospitalization in 2015 for 67 medical conditions in 15 OECD countries: a two-way fixed-effects analysis.(2019) In: CESifo Working Paper Series.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2021The Impact of Biopharmaceutical Innovation on Disability, Social Security Recipiency, and Use of Medical Care of U.S. Community Residents, 1998–2015 In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article0
2002The Effects of Medicare on Health Care Utilization and Outcomes In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article34
2002The Effects of Medicare on Health Care Utilization and Outcomes.(2002) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 34		chapter
2018The Impact of New Drug Launches on Longevity Growth in Nine Middle Eastern and African Countries, 2007–2015 In: Review of Middle East Economics and Finance.
[Full Text][Citation analysis]		article0
1989USING LINKED CENSUS R&D-LRD DATA TO ANALYZE THE EFFECT OF R&D INVESTMENT ON TOTAL FACTOR PRODUCTIVITY GROWTH In: Working Papers.
[Full Text][Citation analysis]		paper5
1989The Effect Of Takeovers On The Employment And Wages Of Central-Office And Other Personnel In: Working Papers.
[Full Text][Citation analysis]		paper8
1989THE EFFECT OF TAKEOVERS ON THE EMPLOYMENT AND WAGES OF CENTRAL-OFFICE AND OTHER PERSONNEL.(1989) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 8		paper
1989The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 8		paper
1989The Effects Of Leveraged Buyouts On Productivity And Related Aspects Of Firm Behavior In: Working Papers.
[Full Text][Citation analysis]		paper192
1990The effects of leveraged buyouts on productivity and related aspects of firm behavior.(1990) In: Journal of Financial Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 192		article
1989The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 192		paper
1997The Allocation of Publicly-Funded Biomedical Research In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper16
2001The Allocation of Publicly Funded Biomedical Research.(2001) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 16		chapter
1998The Allocation of Publicly-Funded Biomedical Research.(1998) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 16		paper
2009Response to Baker and Fugh-Bermans Critique of my Paper, Why has Longevity Increased more in some States than in others? In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper1
2010The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper3
2012The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper2
2014The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data.(2014) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		article
2000The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper6
2001The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey.(2001) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 6		paper
2000Sources of U.S. Longevity Increase, 1960 -1997 In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper14
2002Sources of U.S. Longevity Increase, 1960-1997.(2002) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14		paper
2013The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper0
2015The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence.(2015) In: Social Science & Medicine.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
2015Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010 In: CESifo Working Paper Series.
[Full Text][Citation analysis]		paper0
2015Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010.(2015) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		article
1999Information technology and its impact on firm-level productivity: evidence from government and private data sources, 1977-1993 In: Canadian Journal of Economics.
[Full Text][Citation analysis]		article58
2018The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries In: JODE - Journal of Demographic Economics.
[Full Text][Citation analysis]		article2
.() In: .
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		article
2018The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		paper
2018The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries.(2018) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 2		paper
2010Spurious correlation in estimation of the health production function: A note In: Economics Bulletin.
[Full Text][Citation analysis]		article7
2009Spurious correlation in estimation of the health production function: A note.(2009) In: SOI - Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 7		paper
1999Managerial ownership and firm performance: A re-examination using productivity measurement In: Journal of Corporate Finance.
[Full Text][Citation analysis]		article71
1989IR & D project data and theories of R & D investment In: Journal of Economic Dynamics and Control.
[Full Text][Citation analysis]		article1
1988IR&D Project Data and Theories of R&D Investment.(1988) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
1998International R&D spillovers: A comment In: European Economic Review.
[Full Text][Citation analysis]		article218
1998International R&D spillovers comment.(1998) In: ULB Institutional Repository.
[Citation analysis]
This paper has nother version. Agregated cites: 218		paper
2014The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009 In: Economics & Human Biology.
[Full Text][Citation analysis]		article3
2003The effect of new drug approvals on HIV mortality in the US, 1987-1998 In: Economics & Human Biology.
[Full Text][Citation analysis]		article3
2022The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries In: Economics & Human Biology.
[Full Text][Citation analysis]		article0
1987Changing market opportunities and the structure of R & D investment : The case of energy In: Energy Economics.
[Full Text][Citation analysis]		article1
1995Economics of defense R&D In: Handbook of Defense Economics.
[Full Text][Citation analysis]		chapter20
2014The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010 In: Health Policy.
[Full Text][Citation analysis]		article2
2012Does competition stimulate drug utilization? The impact of changes in market structure on US drug prices, marketing and utilization In: International Review of Law and Economics.
[Full Text][Citation analysis]		article6
1994Ownership structure and corporate performance in Japan In: Japan and the World Economy.
[Full Text][Citation analysis]		article77
1992Ownership Structure and Corporate Performance in Japan.(1992) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 77		paper
1988The burden of government : , Stanford: Hoover Institution Press, 1986. x + 188 pp., $23.95 In: Journal of Comparative Economics.
[Full Text][Citation analysis]		article0
1992Industrial de-diversification and its consequences for productivity In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article54
1990Industrial De-Diversification and Its Consequences for Productivity.(1990) In: Economics Working Paper Archive.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 54		paper
1990Industrial De-Diversification and its Consequences for Productivity.(1990) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 54		paper
1995Labour market institutions, liquidity constraints, and macroeconomic stability In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article0
1991Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability.(1991) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
1995Rejoinder to comment by Maarten Vendrik In: Journal of Economic Behavior & Organization.
[Full Text][Citation analysis]		article0
1989How elastic is the governments demand for weapons? In: Journal of Public Economics.
[Full Text][Citation analysis]		article4
1988HOW ELASTIC IS THE GOVERNMENTS DEMAND FOR WEAPONS?.(1988) In: Columbia - Graduate School of Business.
[Citation analysis]
This paper has nother version. Agregated cites: 4		paper
1989How Elastic is the Governments Demand for Weapons?.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		paper
2004Sources of U.S. longevity increase, 1960-2001 In: The Quarterly Review of Economics and Finance.
[Full Text][Citation analysis]		article27
1986Energy prices and induced innovation In: Research Policy.
[Full Text][Citation analysis]		article21
1990Issues in measuring industrial R&D In: Research Policy.
[Full Text][Citation analysis]		article4
2010Pharmaceutical innovation and mortality in the United States, 1960-2000. A commentary on Schnittker and Karandinos In: Social Science & Medicine.
[Full Text][Citation analysis]		article0
2013The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007 In: Social Science & Medicine.
[Full Text][Citation analysis]		article1
2011The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007.(2011) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2022The impact of biomedical innovation on longevity and health In: Chapters.
[Full Text][Citation analysis]		chapter0
2008Pharmaceutical innovation and the longevity of Australians: A first look In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter4
2008Pharmaceutical innovation and the longevity of Australians: a first look.(2008) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		paper
2010The effect of drug vintage on survival: Micro evidence from Puerto Ricos Medicaid program In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter1
2004The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Ricos Medicaid Program.(2004) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
2012The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter0
2012The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey.(2012) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2003The benefits to society of new drugs: a survey of the econometric evidence In: Proceedings.
[Full Text][Citation analysis]		article2
1996The European Strategic Program for Research in Information Technologie (ESPRIT): An Ex-Post Analysis. In: Columbia - Graduate School of Business.
[Citation analysis]		paper3
1996Computer Use and Productivity Growth in federal Government Agencies. In: Columbia - Graduate School of Business.
[Citation analysis]		paper4
1996The Effect of New Political Administration on Federal Government Productivity and Employment. In: Columbia - Graduate School of Business.
[Citation analysis]		paper1
1996The Effect of New Political Administration on Federal Government Productivity and Employment.(1996) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 1		paper
1988GOVERNMENT SUBSIDIES TO PRIVATE MILITARY R&D INVESTMEN: DODS IR&D POLICY. In: Columbia - Graduate School of Business.
[Citation analysis]		paper5
1988Government Subsidies to Private Military R&D Investment: DODs IR&D Policy.(1988) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 5		paper
1988CROWDING OUT: THE IMPACT OF THE STRATEGIC DEFENSE INITIATIVE ON U.S. CIVILIAN R&D INVESTMENT AND INDUSTRIAL COMPETITIVENESS In: Columbia - Graduate School of Business.
[Citation analysis]		paper0
2020Are patients more adherent to newer drugs? In: Health Care Management Science.
[Full Text][Citation analysis]		article2
2011The quality of medical care, behavioral risk factors, and longevity growth In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article11
2009The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth.(2009) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 11		paper
2015The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011 In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article5
2015The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011.(2015) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 5		paper
2024Has pharmaceutical innovation reduced the average cost of U.S. health care episodes? In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article0
2005The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001 In: International Journal of Health Economics and Management.
[Full Text][Citation analysis]		article33
2003The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 33		paper
1996Book Reviews In: Journal of Economics.
[Full Text][Citation analysis]		article0
1991The Managerial Response to Regulation of Financial Reporting for Segments of a Business Enterprise. In: Journal of Regulatory Economics.
[Citation analysis]		article14
1989The Effects of Mergers on Prices, Costs, And Capacity Utilization in the U.S. Air Transportation Industry, 1970-84 In: Economics Working Paper Archive.
[Full Text][Citation analysis]		paper0
1989The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84.(1989) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2000The Impact of Hospital Quality-Related Practices on Health Outcomes In: Center for Policy Research Working Papers.
[Full Text][Citation analysis]		paper0
1984R&D and Productivity Growth at the Industry Level: Is There Still a Relationship? In: NBER Chapters.
[Full Text][Citation analysis]		chapter126
2005Pharmaceutical Knowledge-Capital Accumulation and Longevity In: NBER Chapters.
[Full Text][Citation analysis]		chapter3
2016The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis In: NBER Chapters.
[Full Text][Citation analysis]		chapter0
2018The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger In: NBER Chapters.
[Full Text][Citation analysis]		chapter0
1981Training, Tenure, and Productivity In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
1982R and D and Productivity at the Industry Level: Is There Still a Relationship? In: NBER Working Papers.
[Full Text][Citation analysis]		paper11
2004The Expanding Pharmaceutical Arsenal in the War on Cancer In: NBER Working Papers.
[Full Text][Citation analysis]		paper11
2004The expanding pharmaceutical arsenal in the war on cancer.(2004) In: 2004 Meeting Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 11		paper
2006The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
2006The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper5
2006Importation and Innovation In: NBER Working Papers.
[Full Text][Citation analysis]		paper8
2007IMPORTATION AND INNOVATION.(2007) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 8		article
2008Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003 In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
2010Has medical innovation reduced cancer mortality? In: NBER Working Papers.
[Full Text][Citation analysis]		paper12
2014Has Medical Innovation Reduced Cancer Mortality?.(2014) In: CESifo Economic Studies.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 12		article
1985The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence In: NBER Working Papers.
[Full Text][Citation analysis]		paper6
2012Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009 In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2013The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
1986Private Investment in R&D to Signal Ability to Perform Government Contracts In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
2015Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients In: NBER Working Papers.
[Full Text][Citation analysis]		paper0
2017The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013 In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2018The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality In: NBER Working Papers.
[Full Text][Citation analysis]		paper4
2019The long-run impact of new medical ideas on cancer survival and mortality.(2019) In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 4		article
2019How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013 In: NBER Working Papers.
[Full Text][Citation analysis]		paper2
1988Technical Change, Learning, and Wages In: NBER Working Papers.
[Full Text][Citation analysis]		paper5
1989The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data In: NBER Working Papers.
[Full Text][Citation analysis]		paper179
1991The Impact of R&D Investment on Productivity--New Evidence Using Linked R&D-LRD Data..(1991) In: Economic Inquiry.
[Citation analysis]
This paper has nother version. Agregated cites: 179		article
2022The Effects of Off-label Drug Use on Disability and Medical Expenditure In: NBER Working Papers.
[Full Text][Citation analysis]		paper0
2022The effects of off-label drug use on disability and medical expenditure.(2022) In: Ruhr Economic Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
1992R&D Investment and International Productivity Differences In: NBER Working Papers.
[Full Text][Citation analysis]		paper125
1993The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis In: NBER Working Papers.
[Full Text][Citation analysis]		paper54
1996The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality In: NBER Working Papers.
[Full Text][Citation analysis]		paper10
1996Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992 In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
1996International R&D Spillovers: A Re-Examination In: NBER Working Papers.
[Full Text][Citation analysis]		paper59
1998Pharmaceutical Innovation, Mortality Reduction, and Economic Growth In: NBER Working Papers.
[Full Text][Citation analysis]		paper24
2001The Effect of New Drugs on Mortality from Rare Diseases and HIV In: NBER Working Papers.
[Full Text][Citation analysis]		paper1
2002Benefits and Costs of Newer Drugs: An Update In: NBER Working Papers.
[Full Text][Citation analysis]		paper15
2007Benefits and costs of newer drugs: an update.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 15		article
2002The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output In: NBER Working Papers.
[Full Text][Citation analysis]		paper3
2002The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs In: NBER Working Papers.
[Full Text][Citation analysis]		paper38
2002The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry In: NBER Working Papers.
[Full Text][Citation analysis]		paper33
2002The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the U.S. Pharmaceuticals Industry.(2002) In: Journal of Law and Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 33		article
.() In: .
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 33		paper
2002Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as equipment for your health In: NBER Working Papers.
[Full Text][Citation analysis]		paper14
2007Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as Equipment for Your Health.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14		article
2003Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act In: NBER Working Papers.
[Full Text][Citation analysis]		paper25
2002Using Patents Data to Map Technical Change in Health-Related Areas In: OECD Science, Technology and Industry Working Papers.
[Full Text][Citation analysis]		paper2
2020The Health Impact of, and access to, New Drugs in Korea In: East Asian Economic Review.
[Full Text][Citation analysis]		article0
2018The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the United States, 1999-2013 In: The American Economist.
[Full Text][Citation analysis]		article0
2006Has Using Newer Drugs Reduced Admissions to Hospitals and Nursing Homes? In: Swiss Journal of Economics and Statistics (SJES).
[Full Text][Citation analysis]		article0
2010Impact of Specialization on Health Outcomes – Evidence from U.S. Cancer Data In: SOI - Working Papers.
[Full Text][Citation analysis]		paper0
2015The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010 In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article2
2013The impact of new (orphan) drug approvals on premature mortality from rare diseases in the United States and France, 1999–2007 In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2022The effects of dynamic and static competition on prescription drug prices in Denmark, 1997–2017 In: Journal of Evolutionary Economics.
[Full Text][Citation analysis]		article0
2017The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013 In: Latin American Economic Review.
[Full Text][Citation analysis]		article0
2006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003 In: PharmacoEconomics.
[Full Text][Citation analysis]		article9
2012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7 In: PharmacoEconomics.
[Full Text][Citation analysis]		article5
2022The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019 In: Swiss Journal of Economics and Statistics.
[Full Text][Citation analysis]		article0
2009The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004 In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]		article5
2024The impact of biomedical innovation on the disability of elderly Medicare recipients, 2013–2019 In: Economics of Innovation and New Technology.
[Full Text][Citation analysis]		article0
2011Has Pharmaceutical Innovation Reduced Social Security Disability Growth? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]		article0
1984Interindustry Technology Flows and Productivity Growth: A Re-examination. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article123
1987The Comparative Advantage of Educated Workers in Implementing New Technology. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article487
1988Estimation of the Internal Adjustment Costs Model Using Longitudinal Establishment Data. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article20
1994Testing the Convergence Hypothesis. In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article88
2001Does Foreign Direct Investment Transfer Technology Across Borders? In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article345
2001Does foreign direct investment transfer technology across borders?.(2001) In: ULB Institutional Repository.
[Citation analysis]
This paper has nother version. Agregated cites: 345		paper
2014The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010 In: Journal of Human Capital.
[Full Text][Citation analysis]		article1
1990The Effect of Ownership Changes on the Employment and Wages of Central Office and Other Personnel. In: Journal of Law and Economics.
[Full Text][Citation analysis]		article49
2021Are drug prices subject to creative destruction? Evidence from the US, 1997–2017 In: Health Economics.
[Full Text][Citation analysis]		article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team